Eastern Connecticut Hematology and Oncology

Norwich, Connecticut 06360-2700

2 studies enrolling now · 7 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Breast Tumor, Cancer, Cancer Metastatic, Chronic Lymphocytic Leukemia, Colon Tumor, Malignant, Endometrial Cancer, Esophageal Cancer, Extensive-stage Small-cell Lung Cancer, Head and Neck Cancer, Homologous Recombination Deficient-Positive Malignancies Agnostic

Studies at this site

• A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
• A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications. — Recruiting now
• To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) — Completed
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
• Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors — Stopped early
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling
• Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2 — Stopped early